Novo Nordisk A/S
NVO
$125.87
-$2.77-2.15%
| Weiss Ratings | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | A+ | |||
| Rating Factors | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.30 | |||
| Price History | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.41% | |||
| 30-Day Total Return | -6.50% | |||
| 60-Day Total Return | 13.65% | |||
| 90-Day Total Return | 27.73% | |||
| Year to Date Total Return | 20.32% | |||
| 1-Year Total Return | 44.38% | |||
| 2-Year Total Return | 117.98% | |||
| 3-Year Total Return | 238.16% | |||
| 5-Year Total Return | 429.56% | |||
| 52-Week High % Change | -9.42% | |||
| 52-Week Low % Change | 65.78% | |||
| Price | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $138.28 | |||
| 52-Week Low Price | $75.56 | |||
| 52-Week Low Price (Date) | Jul 11, 2023 | |||
| 52-Week High Price (Date) | Mar 07, 2024 | |||
| Valuation | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 552.33B | |||
| Enterprise Value | 551.87B | |||
| Price/Earnings (TTM) | 45.42 | |||
| Earnings Per Share (TTM) | 2.70 | |||
| Earnings Per Share Growth | 56.05% | |||
| Price/Earnings To Growth | 0.83 | |||
| Price/Sales (TTM) | 16.30 | |||
| Price/Book (Q) | 34.62 | |||
| Enterprise Value/Revenue (TTM) | 16.54 | |||
| Price | $122.75 | |||
| Enterprise Value/EBITDA (TTM) | 34.34 | |||
| Enterprise Value/EBIT | 36.95 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.48B | |||
| Dividend Yield | 0.80% | |||
| Div. Per Share (Most Recent) | $0.66 | |||
| Dividend Per Share (TTM) | $0.98 | |||
| Payout Ratio (TTM) | 37.90% | |||
| Dividend Per Share (Most Recent) | $0.66 | |||
| Company Info | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 45 44 44 88 88 | |||
| Address | -- | |||
| Website | www.novonordisk.com | |||
| Country | Denmark | |||
| Year Founded | 1923 | |||
| Profitability | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 44.77% | |||
| Profit Margin | 36.03% | |||
| Management Effectiveness | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 23.20% | |||
| Return on Equity | 87.39% | |||
| Income Statement | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 33.71B | |||
| Total Revenue (TTM) | 33.71B | |||
| Revenue Per Share | $7.53 | |||
| Gross Profit (TTM) | 28.52B | |||
| EBITDA (TTM) | 16.24B | |||
| EBIT (TTM) | 15.09B | |||
| Net Income (TTM) | 12.15B | |||
| Net Income Avl. to Common (TTM) | 12.15B | |||
| Total Revenue Growth (Q YOY) | 43.94% | |||
| Earnings Growth (Q YOY) | 69.83% | |||
| EPS Diluted (TTM) | 2.70 | |||
| EPS Diluted Growth (Q YOY) | 71.41% | |||
| Balance Sheet | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.48B | |||
| Cash Per Share (Q) | $1.00 | |||
| Total Current Assets (Q) | 20.71B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 15.80B | |||
| Current Ratio (Q) | 0.823 | |||
| Book Value Per Share (Q) | $3.54 | |||
| Total Assets (Q) | 46.64B | |||
| Total Current Liabilities (Q) | 25.16B | |||
| Total Debt (Q) | 4.00B | |||
| Total Liabilities (Q) | 30.83B | |||
| Total Common Equity (Q) | 15.80B | |||
| Cash Flow | NVO - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -6.37B | |||
| Cash from Financing (TTM) | -9.17B | |||
| Net Change in Cash (TTM) | 275.94M | |||
| Levered Free Cash Flow (TTM) | 7.88B | |||
| Cash from Operations (TTM) | 15.83B | |||
